FDA authorizes Pfizer and Moderna Covid boosters targeted against Omicron strains
Coronavirus,FDA,Coronavirus Vaccine,Booster Shots,CDC,Pfizer,Moderna,BioNTech,BA.5 Variant,Omicron Variant
The Food and Drug Administration on Wednesday authorized new Covid booster shots from Moderna and Pfizer that more closely match the strains of the coronavirus that are currently circulating in the U.S.
Pfizer’s booster, made with partner BioNTech, is being authorized for people as young as 12 years old. The Moderna booster is being authorized for people ages 18 and up.
Use of the new boosters still requires the signoff the Centers for Disease Control and Prevention. The CDC’s vaccine advisory panel is scheduled to meet Thursday and Friday and could vote to recommend them as early as Thursday.
Related Coverage
AllSides Picks
Bias
Media Bias Alert: DOJ Claims Biden Admin Weaponized Gov’t to ‘Chill Free Speech’ Despite Internal Dissent
Andy Gorel
October 8th, 2026
Red Blue Translator
Anti-vaxxer
Headline Roundup
CBS, Trump Admin Offer Competing Accounts of Texas Man's Deportation
October 26th, 2026
Recommended Reading
The State of Self-Censorship in the Classroom
AllSides Staff
October 26th, 2026